Open AccessUse of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States
Author(s) -
Hemalkumar B. Mehta,
Huijun An,
Kathleen M. Andersen,
Omar Mansour,
Vithal Madhira,
E. Rashidi,
Benjamin Bates,
Soko Setoguchi,
Cecil S. Joseph,
Paul T Kocis,
Richard A. Moffitt,
Tellen D. Bennett,
Christopher G. Chute,
Brian T. Garibaldi,
G. Caleb Alexander
Publication year - 2021
Publication title -
annals of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.839
H-Index - 390
eISSN - 1539-3704
pISSN - 0003-4819
DOI - 10.7326/m21-0857
Subject(s) - hydroxychloroquine , medicine , dexamethasone , cohort , covid-19 , cohort study , retrospective cohort study , pediatrics , disease , infectious disease (medical specialty)
Relatively little is known about the use patterns of potential pharmacologic treatments of COVID-19 in the United States.